FTSE 100 Holds Steady as Convatec Leads Gains Amid Market Jitters
The FTSE 100 index demonstrated remarkable resilience on Tuesday, closing with minimal movement for the second consecutive trading session. This stability persisted despite mounting investor anxieties surrounding artificial intelligence disruption and potential US tariff implications. The blue-chip index concluded the day down a mere 4.15 points at 10,680.59, showcasing a market in careful equilibrium.
Mid-Cap and Small-Cap Indices Show Slight Declines
Meanwhile, the FTSE 250 experienced a modest retreat, falling 45.61 points (0.2%) to settle at 23,501.04. The AIM All-Share index similarly edged lower, dropping 0.73 points (0.1%) to close at 815.53. These minor declines reflected a cautious trading environment where corporate earnings reports took centre stage.
Dan Coatsworth, head of markets at AJ Bell, observed: "While investors looked a bit dazed from a wobbly start to the trading week, market movements on Tuesday would suggest they're regaining their balance rather than falling over."
Convatec Surges on Upgraded Growth Forecast
The standout performer was undoubtedly Convatec, whose shares skyrocketed by an impressive 10%. This dramatic rise followed the London-based medical products and technologies provider raising its medium-term guidance and reporting annual results that largely met expectations. The company expressed confidence that growth is "set to accelerate", driven by strategic implementation, recent product launches, and a robust development pipeline.
Consequently, Convatec elevated its organic revenue growth target for 2027 to a range of 6% to 8%, up from the previous 5% to 7% projection. Bank of America analysts noted this new guidance suggests approximately a 7% uplift to consensus estimates. Panmure Liberum analyst Seb Jantet remarked that the results should serve as a "positive catalyst for the share price", reminding investors that despite reimbursement concerns, the company continues to deliver "dependable double-digit earnings growth."
Croda Rises on Strong Financial Performance
Speciality chemicals manufacturer Croda also enjoyed significant investor demand, with shares advancing 7.6%. The Yorkshire-based firm reported higher sales for 2025 and anticipates its profit margin will expand moving forward. Sales increased by 4.4% to £1.7 billion from £1.63 billion the previous year, surpassing the company-compiled consensus of £1.68 billion.
Adjusted pre-tax profit improved by 8.4% to £276.2 million from £260 million, again exceeding consensus expectations of £267.8 million. Looking ahead to 2028, Croda forecasts compound annual revenue growth between 3% and 6%, with an adjusted operating margin expected to exceed 20%, compared to 17.4% in 2025.
Standard Chartered Falls Despite Dividend Boost
In contrast, Standard Chartered shares declined 1.5% as a larger share buyback and stronger-than-anticipated dividend failed to offset a profit miss and ongoing cost concerns. Analysts described the earnings as "untidy", "mixed", and "noisy". Citi analyst Andrew Coombs characterised it as a "mixed" set of results, noting an underlying pre-tax profit shortfall alongside better capital returns and reassuring 2026 targets.
Rentokil Initial also found itself in negative territory, dropping 3.0% after Deutsche Bank Research downgraded the stock from "buy" to "hold". Analyst James Beard acknowledged appreciating the business's long-term fundamentals but cited recent valuation increases, potential near-term growth disappointments, and uncertainty surrounding the new CEO's strategy as reasons for moving to the sidelines.
Global Market Movements and Currency Fluctuations
European equity markets displayed mixed performances. The CAC 40 in Paris closed up 0.3%, while the DAX 40 in Frankfurt ended flat. Across the Atlantic, New York stocks trended higher, with the Dow Jones Industrial Average rising 0.7%, the S&P 500 index gaining 0.6%, and the Nasdaq Composite advancing 0.9%.
Advanced Micro Devices (AMD) soared 7.4% after Meta Platforms secured a deal potentially worth up to $100 billion (£74 billion) to purchase artificial intelligence chips and acquire a 10% stake in the semiconductor company. Rival chipmaker Nvidia saw a modest 0.3% increase ahead of its eagerly awaited earnings report.
Mr Coatsworth added regarding Nvidia: "Investors have plenty to worry about, and Nvidia's results on Wednesday have the potential to make or break the market depending on what it says about AI. The market has this year shown widespread concerns about all things linked to AI, from excessive spending to business models being disrupted, so Nvidia needs to retain its uber-bullish stance if it wants to avoid stirring the pot of worry for investors."
Currency, Commodity, and Bond Market Updates
The pound strengthened to $1.3536 on Tuesday afternoon from $1.3505 at Monday's equities close. The euro softened to $1.1787 from $1.1801. Against the yen, the dollar traded higher at 155.71 yen compared to 154.33 yen.
US Treasury yields remained stable, with the 10-year yield flat at 4.04% and the 30-year yield unchanged at 4.69%. In commodity markets, Brent crude oil traded lower at $71.16 per barrel from $71.96, while gold eased to $5,142.02 an ounce from $5,216.70.
David Morrison, senior market analyst at Trade Nation, commented: "While gold pulled back from Monday's high, the downside appears to be limited by concerns over US president Donald Trump's tariff strategy and ongoing tensions in the Middle East ahead of renewed US–Iran nuclear talks. Fed officials have signalled caution on easing monetary policy too quickly. Yet markets continue to price in at least two 25-basis point rate cuts in 2026, which should prove a supportive backdrop for non-yielding assets."
Notable Stock Movements and Upcoming Events
The FTSE 100's biggest risers included Convatec (up 23.60p at 250.60p), Croda (up 227.00p at 3,212.00p), Antofagasta (up 132.00p at 4,213.00p), Halma (up 90.00p at 4,062.00p), and Hikma Pharmaceuticals (up 34.00p at 1,653.00p). The largest fallers were Melrose (down 29.40p at 640.40p), Rentokil Initial (down 13.60p at 445.70p), Rightmove (down 8.80p at 415.50p), British Land (down 8.60p at 408.40p), and M&G (down 6.30p at 311.70p).
Ashmore climbed 2.9% following a Jefferies upgrade to "buy" from "hold", while Unite slumped 14% after forecasting lower 2026 earnings per share, citing occupancy pressures from more students living at home and declining international postgraduate numbers.
Wednesday's economic calendar features Australian inflation data, eurozone CPI figures, and German GDP statistics. Corporate reports are expected from Diageo, Haleon, and HSBC.
